Showing Results for
- Academic Journals (123)
Search Results
- 123
Academic Journals
- 123
-
From:Oncology (Vol. 28, Issue 6) Peer-ReviewedThanks to stage migration from prostate-specific antigen (PSA) screening, less than 5% of cases of newly diagnosed prostate cancer are currently node-positive, but as screening rates begin to fall in the United States,...
-
From:Clinical Advisor (Vol. 17, Issue 4)Prostate cancer (PC) is the most common male-related malignancy in the United States, the second most common cause of cancer-related death among U.S. men, and the fourth most prevalent male malignancy worldwide. (1),...
-
From:PLoS ONE (Vol. 14, Issue 3) Peer-ReviewedBackground Watson for oncology (WFO) is a cognitive computing system providing decision support. We evaluated the concordance rates between the treatment options determined by WFO and those determined by a...
-
From:Urologic Nursing (Vol. 39, Issue 2) Peer-ReviewedNew therapies and evolving scientific concepts are significantly improving outcomes for patients with prostate cancer. A greater emphasis on delivering stateof-the-art nursing care and personalization of treatments is...
-
From:Archives of Pathology & Laboratory Medicine (Vol. 144, Issue 6) Peer-Reviewed* Context.--Cancer immunotherapy provides unprecedented rates of durable clinical benefit to late-stage cancer patients across many tumor types, but there remains a critical need for biomarkers to accurately predict...
-
From:Oncology (Vol. 35, Issue 4) Peer-ReviewedOvarian cancer is the fifth most common cause of cancer deaths in women and the leading cause of death among cancers of the female reproductive system in the United States. More than 21,400 women in the United States are...
-
From:Oncology (Vol. 23, Issue 3) Peer-ReviewedThe National Comprehensive Cancer Network (NCCN) has announced the addition of a survivorship section to the NCCN Clinical Practice Guidelines in Oncology for colon and rectal cancers, as well as other key updates in...
-
From:Oncology (Vol. 26, Issue 11) Peer-ReviewedChronic lymphocytic leukemia (CLL) is a very heterogeneous disease with significant variation in clinical presentation, time to disease progression, survival, and aggressiveness of clinical course. A subgroup of...
-
From:Oncology (Vol. 28, Issue 11) Peer-ReviewedThe completion of the National Lung Screening Trial (NLST), a randomized controlled trial (RCT) of lung cancer screening (LCS), in 2010 provided powerful RCT evidence of the efficacy and safety of computed...
-
From:Pharmaceutical Medicine (Vol. 23, Issue 4) Peer-ReviewedIn the US, the National Comprehensive Cancer Network has updated its infection guidelines to cover H1N1 virus (swine flu). The network's Clinical Practice Guidelines in Oncology for the Prevention and Treatment of...
-
From:Expert Review of Anticancer Therapy (Vol. 3, Issue 3) Peer-ReviewedThe National Comprehensive Cancer Network (NCCN) has issued new Cancer and Treatment-Related Anemia Practice Guidelines. The guidelines enumerate the connection between hemoglobin (Hb) levels and symptom management,...
-
From:PLoS ONE (Vol. 15, Issue 1) Peer-ReviewedBackground Chronic lymphocytic leukemia (CLL) is incurable through conventional chemoimmunotherapy regimens. Despite durable responses to front-line therapy and sustained remission rates in patients with CLL, a...
-
From:Journal of Oncology (Vol. 2021) Peer-ReviewedBackground. Adjuvant chemotherapy (ACT) can improve prognosis for stages II-IIIA patients with non-small-cell lung cancer (NSCLC), but its implication in stage I patients is still an intractable puzzle. This study aims...
-
From:Perspectives in Clinical Research (Vol. 13, Issue 2) Peer-ReviewedByline: Aakanksha. Sharma, Himanshu. Patel, Gurumurthy. Parthasarathi Aims/Objectives: This study was conducted to assess the utilization patterns of anticancer agents in patients with breast cancer and to provide...
-
From:Journal of Hematology & Oncology (Vol. 15, Issue 1) Peer-ReviewedMultiparametric magnetic resonance imaging (mpMRI) is an emerging standard for diagnosing and prognosing prostate cancer, but ~ 20% of clinically significant tumors are invisible to mpMRI, as defined by the Prostate...
-
From:Canadian Urological Association Journal (Vol. 9, Issue 6) Peer-ReviewedSmall renal masses (SRM) are encountered by most urologists as part of their routine clinical practice, which makes best practice statements or guidelines like those published in this month's CUAJ important in...
-
From:Family Practice News (Vol. 48, Issue 8)KAUAI, HAWAII -- Melanoma staging in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual implements better stratification of stage III melanoma patients, resulting in an evidence-based improved...
-
From:Clinical Advisor (Vol. 22, Issue 1)The National Institutes of Health Human Genome Project, initiated in April 1999, was the first collaborative research initiative to map and sequence a reference human genome completely. (1,2) Currently, the whole-genome...
-
From:Journal of Oncology (Vol. 2020) Peer-ReviewedGermline pathogenic alterations in the breast cancer susceptibility genes 1 (BRCA1) and 2 (BRCA2) are the most prevalent causes of hereditary breast and ovarian cancer. The increasing trend in proportion of cancer...
-
From:Indian Journal of Urology (Vol. 36, Issue 4) Peer-ReviewedByline: Shanky. Singh, Saurabh. Patil, Ashwin. Tamhankar, Puneet. Ahluwalia, Gagan. Gautam We thank our esteemed readers for their interest in our recent manuscript and their insightful comments on the same.[1] We...